Gyre Therapeutics, Inc. planned insider sales
In the last twelve months insiders at Gyre Therapeutics, Inc. filed 2 Form 144 notices of planned sales, 848,000 shares worth $6.7 million at the time of filing, from 1 seller. The latest, filed 11 May 2026: Ye Weiguo (officer), 300,000 shares worth $2.1 million, planned for around 13 May 2026 through Futu Securities International(Hong Kong) Ltd..
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 11 May 2026 | Ye Weiguo | Officer | 300,000 | $2.1 million | 13 May 2026 | 137,414 shares from 14 May 2026 | Futu Securities International(Hong Kong) Ltd. | Stock Option Exercise | Form 144 |
| 13 November 2025 | Ye Weiguo | Officer | 548,000 | $4.6 million | 15 November 2025 | No matching Form 4 sale | Futu Securities International (Hong Kong) Limited | Stock Option Exercise | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.